Clinical trial demonstrates effects of sulodexide on endothelial glycocalyx and vascular permeability in type 2 diabetes, indicating therapeutic potential for vascular barrier protection.
An unrestricted Novartis Foundation for Cardiovascular Excellence grant (2006) to M. Nieuwdorp/E. S. G. Stroes, Dutch Heart Foundation (grant number 2005T037).
No takes yet. Share an insight, caveat, or question.
Broekhuizen et al. (2010) studied this question.